SCHEMBL10330868

SCHEMBL10330868

CNCN(C)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15120327 0.86 PRMT3 (0.32)
SCHEMBL13589014 0.79
SCHEMBL12901250 0.78 CYP2C9 (0.32)
SCHEMBL14578314 0.73 PRMT3 (0.40)
SCHEMBL17717507 0.73
SCHEMBL12660310 0.73
SCHEMBL7193560 0.71
SCHEMBL24049334 0.71
SCHEMBL2733533 0.71
SCHEMBL12901249 0.71 PRMT3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3277286-B1 BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF ENANTA PHARM INC (US) 2021-04-21 EP disclosed
US-20120183564-A1 INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION DUKE UNIVERSITY 2012-07-19 US disclosed